microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma

References

• XiongYFangJHYunJPEffects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinomaHepatology201051383684520041405
   PubMed Web of Science ®Google Scholar
• FornariFGramantieriLFerracinMMiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinomaOncogene200827435651566118521080
   PubMed Web of Science ®Google Scholar
• SuHYangJRXuTMicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicityCancer Res20096931135114219155302
   PubMed Web of Science ®Google Scholar
• FangJHZhouHCZengCMicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metallo-proteinase 2 expressionHepatology20115451729174021793034
   PubMed Web of Science ®Google Scholar
• BudhuAJiaHLForguesMIdentification of metastasis-related microRNAs in hepatocellular carcinomaHepatology200847389790718176954
   PubMed Web of Science ®Google Scholar
• AignerAMicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAsJ Mol Med (Berl)201189544545721234533
   PubMed Web of Science ®Google Scholar
• ZengCWZhangXJLinKYCamptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathwaysMol Pharmacol201281457858622252650
   PubMed Web of Science ®Google Scholar
• ZhuWShanXWangTShuYLiuPmiR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell linesInt J Cancer2010127112520252920162574
   PubMed Web of Science ®Google Scholar
• NieJLiuLZhengWmicroRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2Carcinogenesis201233122022522072615
   PubMed Web of Science ®Google Scholar
• LuJHeMLWangLMiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2Cancer Res201171122523321199804
   PubMed Web of Science ®Google Scholar
• VisoneRPallantePVecchioneASpecific microRNAs are downregulated in human thyroid anaplastic carcinomasOncogene200726547590759517563749
   PubMed Web of Science ®Google Scholar
• CiarapicaRRussoGVerginelliFDeregulated expression of miR-26a and Ezh2 in rhabdomyosarcomaCell Cycle20098117217519106613
   PubMed Web of Science ®Google Scholar
• ZhangBLiuXXHeJRPathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancerCarcinogenesis20113212920952513
   PubMed Web of Science ®Google Scholar
• SalvatoriBIosueIMangiavacchiAThe microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cellsCell Death Dis20123e41323096114
   PubMed Web of Science ®Google Scholar
• SanderSBullingerLKlapprothKMYC stimulates EZH2 expression by repression of its negative regulator miR-26aBlood2008112104202421218713946
   PubMed Web of Science ®Google Scholar
• KotaJChivukulaRRO’DonnellKATherapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer modelCell200913761005101719524505
   PubMed Web of Science ®Google Scholar
• JiJShiJBudhuAMicroRNA expression, survival, and response to interferon in liver cancerN Engl J Med2009361151437144719812400
   PubMed Web of Science ®Google Scholar
• YangXLiangLZhangXFMicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting IL-6-Stat3 pathwayHepatology201358115817023389848
   PubMed Web of Science ®Google Scholar
• MazzaferroVRomitoRSchiavoMPrevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosisHepatology20064461543155417133492
   PubMed Web of Science ®Google Scholar
• LlovetJMSalaMCastellsLRandomized controlled trial of interferon treatment for advanced hepatocellular carcinomaHepatology2000311545810613728
   PubMed Web of Science ®Google Scholar
• SomeyaTIkedaKSaitohSInterferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma: a pilot study of patients with hepatitis B virus-related cirrhosisJ Gastroenterol200641121206121317287900
   PubMed Web of Science ®Google Scholar
• SunHCTangZYWangLPostoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trialJ Cancer Res Clin Oncol2006132745846516557381
   PubMed Web of Science ®Google Scholar
• SakonMNaganoHDonoKCombined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branchesCancer200294243544211900229
   PubMed Web of Science ®Google Scholar
• OtaHNaganoHSakonMTreatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expressionBr J Cancer200593555756416106266
   PubMed Web of Science ®Google Scholar
• NaganoHWadaHKobayashiSLong-term outcome of combined interferon-alpha and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosisOncology2011801–2636921659784
   PubMed Web of Science ®Google Scholar
• ObiSYoshidaHTouneRCombination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasionCancer200610691990199716565970
   PubMed Web of Science ®Google Scholar
• VazquezABondEELevineAJBondGLThe genetics of the p53 pathway, apoptosis and cancer therapyNat Rev Drug Discov200871297998719043449
   PubMed Web of Science ®Google Scholar
• FuldaSRegulation of apoptosis pathways in cancer stem cellsCancer Lett2013338116817322429999
   PubMed Web of Science ®Google Scholar
• JohnstoneRWRuefliAALoweSWApoptosis: a link between cancer genetics and chemotherapyCell200210815316411832206
   PubMed Web of Science ®Google Scholar
• JohnstoneRWFrewAJSmythMJThe TRAIL apoptotic pathway in cancer onset, progression and therapyNat Rev Cancer2008878279818813321
   PubMed Web of Science ®Google Scholar
• ZhouJJuWWangDDown-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regenerationPLoS One201274e3357722496754
   PubMed Web of Science ®Google Scholar
• ZhuYLuYZhangQMicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb proteinNucleic Acids Res201240104615462522210897
   PubMed Web of Science ®Google Scholar
• ChenLZhengJZhangYTumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathwaysMol Ther20111981521152821610700
   PubMed Web of Science ®Google Scholar
• KarstAMLiGBH3-only proteins in tumorigenesis and malignant melanomaCell Mol Life Sci200764331833017192811
   PubMed Web of Science ®Google Scholar
• CotterTGApoptosis and cancer: the genesis of a research fieldNat Rev Cancer20099750150719550425
   PubMed Web of Science ®Google Scholar
• YipKWReedJCBcl-2 family proteins and cancerOncogene200827506398640618955968
   PubMed Web of Science ®Google Scholar
• CorySAdamsJMThe Bcl2 family: regulators of the cellular life-or-death switchNat Rev Cancer20022964765612209154
   PubMed Web of Science ®Google Scholar
• RodriguezJLazebnikYCaspase-9 and APAF-1 form an active holoenzymeGenes Dev199913243179318410617566
   PubMed Web of Science ®Google Scholar
• AcehanDJiangXMorganDGHeuserJEWangXAkeyCWThree-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activationMol Cell20029242343211864614
   PubMed Web of Science ®Google Scholar
• LezinaLPurmessurNAntonovAVmiR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stressCell Death Dis20134e95324336073
   PubMed Web of Science ®Google Scholar